From the beginning of public vaccinations until the relaxation of COVID-19 measures, many
case reports, case series and case–control studies have been published indicating …

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …

Idiopathic Multicentric Castleman Disease (iMCD) is a potentially life-threatening systemic
disease whose complex symptomatology is due to cytokine dysregulation. We, herein …

Abstract Background Adult-onset Still's disease (AOSD) is a multi-system, auto-inflammatory
disease characterized by fever, arthralgia, typical rash, leukocytosis, sore throat, and liver …

Background The SARS-CoV-2 mRNA vaccine has been reported to cause various adverse
reactions, including the development or exacerbation of autoimmune diseases, but the …

The presence of neutralizing antibodies against SARS-CoV-2 correlates with protection
against infection and severe COVID-19 disease courses. Understanding the dynamics of …

We report the case of an 18-year-old male with Still's disease for the last 3 years, in
remission, who developed two flares of his disease after receiving two doses of the …

Background The innate immune cytokine interleukin (IL)-1 can affect T cell immunity, a
critical factor in host defense. In a previous study, we identified a subset of human CD4+ T …

SARS-CoV-2 vaccines have been rapidly deployed worldwide. They have proved to be
generally safe and effective at preventing severe disease by eliciting a strong immune …

A spectrum of adverse cutaneous reactions has been reported after COVID-19 vaccinations,
with 15%–35% of patients reporting erythema, swelling, induration and/or itch. The …